Evidence map›Paper›PMID 37257955›Full record

ReviewJournal of the American College of Cardiology2023

Multidisciplinary Critical Care Management of Electrical Storm: JACC State-of-the-Art Review.

Jacob C Jentzer, Peter A Noseworthy, Anthony H Kashou, Adam M May, Jonathan Chrispin, Rajesh Kabra, Kelly Arps, Vanessa Blumer, James E Tisdale, Michael A Solomon and 1 more

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Journal of the American College of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07375264 (Long-term Outcomes of Ultrasound-guided Percutaneous Bilateral Cardiac Sympathetic Denervation in Patients With Refractory Arrhythmic Storm), which is not on this map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07375264 completednot on this map

Long-term Outcomes of Ultrasound-guided Percutaneous Bilateral Cardiac Sympathetic Denervation in Patients With Refractory Arrhythmic Storm: a Single-center Case Series

Typeobservational_patient_registrySponsorJose Manuel López GonzálezRan2023 to 2025Enrolled18ConditionsVentricular Arrhythmias, Electrical Storm, Stellate Ganglion BlockArmsCardiac sympathetic denervation.
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. A practical 5-stage clinical scale for electrical storm: the STORM classification.European heart journal. Acute cardiovascular care · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Jacob C JentzerDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: jentzer.jacob@mayo.edu.
Peter A NoseworthyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Anthony H KashouDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Adam M MayCardiovascular Division, Washington University School of Medicine, St Louis, Missouri, USA.
Jonathan ChrispinClinical Cardiac Electrophysiology, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Rajesh KabraKansas City Heart Rhythm Institute, Overland Park, Kansas, USA.
Kelly ArpsCardiac Electrophysiology Section, Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Vanessa BlumerDepartment of Cardiology, Cleveland Clinic, Cleveland, Ohio, USA.
James E TisdaleCollege of Pharmacy, Purdue University, West Lafayette, Indiana, USA; School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Michael A SolomonCritical Care Medicine Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, Maryland, USA; Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
American College of Cardiology Critical Care Cardiology and Electrophysiology Sections
Mayo Clinic · USCleveland Clinic · USDuke Medical Center · USHeart Rhythm Society · USJohns Hopkins University · USNational Institutes of Health · USPurdue University West Lafayette · USWashington University in St. Louis · US

Funding

NESTcc Renewal -Continuation of the National Evaluation System for Health Technology (NEST) Coordinating Center (CC)U01FD006292 · FDA · MEDICAL DEVICE INNOVATION CONSORTIUM · PI SMITH, RICHARD · 2018 to 2025
$76.1M
CARDIOVASOLOGYT32HL007111 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug · 1985 to 2026
$8.7M
Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib)R01HL131535 · NHLBI · MAYO CLINIC ROCHESTER · PI MONTORI, VICTOR MANUEL · 2016 to 2020
$3.2M
Influence of genetic variation on QT prolongation over the lifecourse and as a cardiotoxic drug responseR01HL143070 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NEWTON-CHEH, CHRISTOPHER HOLMES · 2018 to 2021
$3.0M
Optimizing stroke prevention for older adults with atrial fibrillation: Towards rigorous evaluation and judicious application of a new deviceR01AG062436 · NIA · MAYO CLINIC ROCHESTER · PI NOSEWORTHY, PETER A, YAO, XIAOXI · 2020 to 2024
$2.5M
Gastrointestinal Safety of Antithrombotic Drug RegimensR01HS025402 · AHRQ · MAYO CLINIC ARIZONA · PI ABRAHAM, NEENA S · 2017 to 2020
$1.6M
Multimorbidity, Rurality, and Outcomes in Atrial Fibrillation in the CommunityR21AG062580 · NIA · MAYO CLINIC ROCHESTER · PI CHAMBERLAIN, ALANNA M · 2019 to 2020
$451k
AHRQ HHS R01 HS025402FDA HHS U01 FD006292NHLBI NIH HHS R01 HL131535NHLBI NIH HHS R01 HL143070NHLBI NIH HHS T32 HL007111NIA NIH HHS R01 AG062436NIA NIH HHS R21 AG062580
6 · The paper itself

Abstract

Electrical storm (ES) reflects life-threatening cardiac electrical instability with 3 or more ventricular arrhythmia episodes within 24 hours. Identification of underlying arrhythmogenic cardiac substrate and reversible triggers is essential, as is interrogation and programming of an implantable cardioverter-defibrillator, if present. Medical management includes antiarrhythmic drugs, beta-adrenergic blockade, sedation, and hemodynamic support. The initial intensity of these interventions should be matched to the severity of ES using a stepped-care algorithm involving escalating treatments for higher-risk presentations or recurrent ventricular arrhythmias. Many patients with ES are considered for catheter ablation, which may require the use of temporary mechanical circulatory support. Outcomes after ES are poor, including frequent ES recurrences and deaths caused by progressive heart failure and other cardiac causes. A multidisciplinary collaborative approach to the management of ES is crucial, and evaluation for heart transplantation or palliative care is often appropriate, even for patients who survive the initial episode.

Indexed as

Catheter AblationDefibrillators, ImplantableHeart TransplantationTachycardia, VentricularAnti-Arrhythmia AgentsArrhythmias, CardiacHumansAnti-Arrhythmia Agentscardiomyopathyheart failureimplantable cardioverter-defibrillatormyocardial infarctionshocksudden cardiac deathventricular fibrillationventricular tachycardia

Identifiers

PMID37257955
PMCPMC10683004
OpenAlexW4378700845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.